Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3318895
Max Phase: Preclinical
Molecular Formula: C12H23NO2
Molecular Weight: 213.32
Molecule Type: Small molecule
Associated Items:
ID: ALA3318895
Max Phase: Preclinical
Molecular Formula: C12H23NO2
Molecular Weight: 213.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COCCO[C@H]1CC[C@H]2CCN(C)[C@H]2C1
Standard InChI: InChI=1S/C12H23NO2/c1-13-6-5-10-3-4-11(9-12(10)13)15-8-7-14-2/h10-12H,3-9H2,1-2H3/t10-,11-,12-/m0/s1
Standard InChI Key: QFMIFNPQAHGAST-SRVKXCTJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 213.32 | Molecular Weight (Monoisotopic): 213.1729 | AlogP: 1.52 | #Rotatable Bonds: 4 |
Polar Surface Area: 21.70 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.12 | CX LogP: 1.02 | CX LogD: -1.64 |
Aromatic Rings: 0 | Heavy Atoms: 15 | QED Weighted: 0.66 | Np Likeness Score: 0.58 |
1. Jepsen TH, Jensen AA, Lund MH, Glibstrup E, Kristensen JL.. (2014) Synthesis and Pharmacological Evaluation of DHβE Analogues as Neuronal Nicotinic Acetylcholine Receptor Antagonists., 5 (7): [PMID:25050162] [10.1021/ml500094c] |
Source(1):